News | December 19, 2025
Takeda joins BaseLaunch to boost early-stage biotech ventures in Europe
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
The move strengthens GBL’s clinical-stage presence in the United States
India plays a critical role in Bristol Myers Squibb’s global strategy
Clinical trial enrollment has long been a bottleneck in drug development
Ryght AI tackles these hurdles with its AI Site Twin platform
Updated results from the EMBER-3 study showed that the drug -- Inluriyo (imlunestrant) -- as a standalone treatment cut the risk of progression or death by 38%
The Healey ALS Platform Trial is a multicenter, double-blind, placebo-controlled
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Jacobio stated that these findings underscore the potential of glecirasib and sitneprotafib
This is the first time in history that an NDA for a New Chemical Entity (NCE) from an Indian pharmaceutical company has been filed and accepted by the USFDA
Subscribe To Our Newsletter & Stay Updated
